Follow Us

FDA panel supports over-the-counter birth control pill, paving way for final, US approval

Opill may become the first contraceptive medication to be moved from a prescription-only basis to the store shelves.

Published: May 10, 2023 1:44pm

An advisory panel at the U.S. Food and Drug Administration on Wednesday said that a decades-old birth control pill should be sold without a prescription, paving the way for the first over-the-counter contraceptive pill to be approved nationally. 

In a unanimous vote, the FDA advisers supported pharmaceutical manufacturer Perrigo’s request to sell its daily birth control pill, Opill, over the counter. 

The recommendation is non-binding, but if the FDA follows it, then Opill would become the first contraceptive medication to be moved from a prescription-only basis to the store shelves.

Madeleine Hubbard is an international correspondent for Just the News. Follow her on Twitter or Instagram.

The Facts Inside Our Reporter's Notebook

Just the News Spotlight